Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-BiRD in newly diagnosed multiple myeloma
NCT00538733Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2007
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in multiple myeloma (MM), sponsored by Weill Cornell Medicine. Started Oct 2007; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00538733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538733.